Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Earl

Showing results (181-190 of 265) with videos related to

Pageof 27
Sort By:
British Journal of Cancer|September 18, 2008
NEAT: National Epirubicin Adjuvant Trial--toxicity, delivered dose intensity and quality of lifeH M Earl, L Hiller, J A Dunn, et al.
Journal of Clinical Microbiology|December 2, 2016
Whole-Genome Sequencing of Mycobacterium tuberculosis Provides Insight into the Evolution and Genetic Composition of Drug-Resistant Tuberculosis in BelarusKurt R Wollenberg, Christopher A Desjardins, Aksana Zalutskaya, et al.
Mbio|August 22, 2013
Emergence of epidemic multidrug-resistant Enterococcus faecium from animal and commensal strainsFrançois Lebreton, Willem van Schaik, Abigail Manson McGuire, et al.
Open Forum Infectious Diseases|January 7, 2021
Acquisition and Long-term Carriage of Multidrug-Resistant Organisms in US International TravelersColin J Worby, Ashlee M Earl, Sarah E Turbett, et al.
Breast Cancer Research and Treatment|June 19, 2010
Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group studyJanine L Mansi, Ann Yellowlees, Julian Lipscombe, et al.
Plos Medicine|December 21, 2016
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective StudyChristine A Parkinson, Davina Gale, Anna M Piskorz, et al.
Nature Medicine|June 27, 2020
Author Correction: Adaptive evolution of virulence and persistence in carbapenem-resistant Klebsiella pneumoniaeChristoph M Ernst, Julian R Braxton, Carlos A Rodriguez-Osorio, et al.
Nature Medicine|April 15, 2020
Adaptive evolution of virulence and persistence in carbapenem-resistant Klebsiella pneumoniaeChristoph M Ernst, Julian R Braxton, Carlos A Rodriguez-Osorio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2014
Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with PaclitaxelJean E Abraham, Qi Guo, Leila Dorling, et al.
Nature Communications|November 13, 2014
Unencapsulated Streptococcus pneumoniae from conjunctivitis encode variant traits and belong to a distinct phylogenetic clusterMichael D Valentino, Abigail Manson McGuire, Jason W Rosch, et al.
Pageof 27

Showing results (181-190 of 265) with videos related to

Sort By:
Pageof 27
British Journal of Cancer|September 18, 2008
NEAT: National Epirubicin Adjuvant Trial--toxicity, delivered dose intensity and quality of lifeH M Earl, L Hiller, J A Dunn, et al.
Journal of Clinical Microbiology|December 2, 2016
Whole-Genome Sequencing of Mycobacterium tuberculosis Provides Insight into the Evolution and Genetic Composition of Drug-Resistant Tuberculosis in BelarusKurt R Wollenberg, Christopher A Desjardins, Aksana Zalutskaya, et al.
Mbio|August 22, 2013
Emergence of epidemic multidrug-resistant Enterococcus faecium from animal and commensal strainsFrançois Lebreton, Willem van Schaik, Abigail Manson McGuire, et al.
Open Forum Infectious Diseases|January 7, 2021
Acquisition and Long-term Carriage of Multidrug-Resistant Organisms in US International TravelersColin J Worby, Ashlee M Earl, Sarah E Turbett, et al.
Breast Cancer Research and Treatment|June 19, 2010
Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group studyJanine L Mansi, Ann Yellowlees, Julian Lipscombe, et al.
Plos Medicine|December 21, 2016
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective StudyChristine A Parkinson, Davina Gale, Anna M Piskorz, et al.
Nature Medicine|June 27, 2020
Author Correction: Adaptive evolution of virulence and persistence in carbapenem-resistant Klebsiella pneumoniaeChristoph M Ernst, Julian R Braxton, Carlos A Rodriguez-Osorio, et al.
Nature Medicine|April 15, 2020
Adaptive evolution of virulence and persistence in carbapenem-resistant Klebsiella pneumoniaeChristoph M Ernst, Julian R Braxton, Carlos A Rodriguez-Osorio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2014
Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with PaclitaxelJean E Abraham, Qi Guo, Leila Dorling, et al.
Nature Communications|November 13, 2014
Unencapsulated Streptococcus pneumoniae from conjunctivitis encode variant traits and belong to a distinct phylogenetic clusterMichael D Valentino, Abigail Manson McGuire, Jason W Rosch, et al.
Pageof 27